2m 2m 2m 2m 2m 2m 2m
Cell Source (CLCS)
OTC
$0.58+$0.001 (+0.23%)
Price as of Aug 21, 2026- $39.5MMarket Cap
- 41.79%1-Year Change
- BiotechnologyIndustry
Cell Source (CLCS)
$0.58+$0.001 (+0.23%)
CLCS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.58 | ||
Change | +$0.001 (+0.23%) | ||
Open | $0.58 | ||
High | $0.65 | ||
Low | $0.51 | ||
Previous Close | $0.58 | ||
Volume | 4,300 | ||
30-Day Average Volume | 3,877 | ||
1-Week Change | -3.10% | ||
1-Month Change | -27.33% | ||
1-Year Change | 41.79% | ||
3-Year Change | 21,430.67% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 67.9M | ||
Total Assets | $292,446.00 | ||
Market Cap | $39.5M | ||
Enterprise Value | $42.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.8M | ||
Free Cash Flow | -$600,391.00 | ||
EBIT | -$1.6M | ||
EBITDA | -$1.6M | ||
Net Working Capital | -$4.5M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -2 | ||
P/E | -15 | ||
PEG | 7 | ||
Price/Free Cash Flow | -66 | ||
Price/Operating Cash Flow | -66 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||